KRT88P and infection: Xu et al. [90] generated a fusion protein with hepatitis B virus core protein (HBc) and VP2 epitope corresponding to amino acids 141–155 of VP2, named HBc-VP2 (aa141–155), which induced cross-neutralizing EV-A71 antibodies, and the anti-sera from HBc-VP2 (aa141–155) immunized mice protected newborn mice from EV-A71 infection.